Changeflow GovPing Healthcare GEM Premier 5000 Device Recall - PCSND Errors
Urgent Enforcement Amended Final

GEM Premier 5000 Device Recall - PCSND Errors

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has issued a Class II recall for the GEM Premier 5000 device due to an increased incidence of Process Control Solution Not Detected (PCSND) errors. This recall affects worldwide distribution, including the United States.

What changed

The FDA has initiated a Class II device recall for the GEM Premier 5000, part number 00055430008, due to confirmed customer complaints of frequent Process Control Solution Not Detected (PCSND) errors during the warm-up phase. These errors can lead to GEM PAK ejection, requiring re-insertion and potentially impacting diagnostic accuracy and workflow.

Healthcare providers using the GEM Premier 5000 should be aware of this recall and monitor for PCSND errors. While the document indicates worldwide distribution, specific actions for affected entities are not detailed in this recall notice. Compliance officers should review internal device logs for error occurrences and consult Instrumentation Laboratory's advisories for any specific remediation steps or reporting requirements related to this recall.

What to do next

  1. Review internal logs for PCSND errors on GEM Premier 5000 devices.
  2. Consult Instrumentation Laboratory advisories for remediation steps.

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1538-2026 · 20260318 · Ongoing

Product

GEM Premier 5000; Part No. 00055430008.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1538-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Device Recalls Medical Device Operations
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Product Safety Healthcare Operations

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.